Ad is loading...
MENU

XFOR X4 Pharmaceuticals Forecast, Technical & Fundamental Analysis

a biotechnology company which engages in developing human antibodies for treating infectious diseases

Industry Biotechnology
XFOR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
XFOR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XFOR is expected to report earnings to fall 11.11% to -15 cents per share on March 13

X4 Pharmaceuticals XFOR Stock Earnings Reports
Q4'24
Est.
$-0.16
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.46
Q1'24
Missed
by $0.12
Q4'23
Beat
by $0.05
The last earnings report on November 13 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 3.93M shares outstanding, the current market capitalization sits at 67.99M.
A.I. Advisor
published General Information

General Information

a biotechnology company which engages in developing human antibodies for treating infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
61 North Beacon Street
Phone
+1 857 529-8300
Employees
93
Web
https://www.x4pharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
T22.680.43
+1.93%
AT&T
AGNC9.580.07
+0.74%
AGNC Investment Corp
RNST36.910.16
+0.44%
Renasant Corp
ENZ1.04N/A
N/A
Enzo Biochem
MED18.14-0.14
-0.77%
Medifast

XFOR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with SYRS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then SYRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
-1.59%
SYRS - XFOR
50%
Loosely correlated
-5.74%
IMMP - XFOR
35%
Loosely correlated
-1.91%
BEAM - XFOR
34%
Loosely correlated
-8.59%
XCUR - XFOR
34%
Loosely correlated
-8.81%
SPHDF - XFOR
34%
Loosely correlated
N/A
More